Tiantong Launches TTOS Orthokeratology Lens Nationwide with 'Bright Eyes, Brilliant Future' Event
Urgent Action Is Needed to Prevent and Control Myopia Among Adolescents in ChinaIn China’s demographic structure of myopia patients, the number of children and adolescents with myopia totals approximately 270 million, ranking first worldwide. Under the “Healthy China” strategy, the prevention and control of myopia among children and adolescents has become a key component. The Chinese government continues to issue various policy documents to enhance the standards of myopia prevention, control, and correction. Addressing myopia among Chinese adolescents requires a dual approach: improving daily eye-use habits to prevent onset, and employing scientific correction methods to slow its progression.
Orthokeratology lenses (OK lenses) can effectively retard pathological axial elongation, demonstrate significant efficacy in myopia prevention, and ensure clinical safety, making them one of the most effective interventions currently used in clinical practice for myopia control. The current market penetration rate of orthokeratology lenses in China is only 1.26%, and it is projected to reach 10.66% by 2030, indicating substantial growth potential.
On December 18, the national launch event for the Tiantong TTOS Orthokeratology Lens was successfully held in Shanghai, marking the official market entry of another major domestically produced product in this field.Since its inception, Zhejiang Tiantong Medical Device Co., Ltd. has introduced advanced technologies from the United States to localize the research and development of orthokeratology lenses in China. Relying on clinical studies conducted in collaboration with renowned domestic ophthalmic hospitals, and after eight years of iterative refinement and continuous improvement, the company successfully obtained the Class III Medical Device Registration Certificate (National Medical Products Administration Approval No. 20223160792) from the National Medical Products Administration in June 2022. The company boasts a robust R&D team and a comprehensive production and quality management system. It has established cleanroom production workshops that exceed international standards, introduced the latest generation of advanced manufacturing equipment, and developed standardized, high-level production processes and workflows.
From left to right: Mr. Wang Dong, Ms. Wu Ying, Professor Zhou Jiaqi, Professor Mao Xinjie, Ms. Jin Jianya, Mr. Wang Hongbo
This launch event has invitedNotable ophthalmology experts in attendance included Professor Lv Fan from the Eye Hospital of Wenzhou Medical University, Professor Zhou Xingtao from the Eye & ENT Hospital of Fudan University, Professor Zeng Junwen from Zhongshan Ophthalmic Center at Sun Yat-sen University, Professor Li Lihua from Tianjin Eye Hospital, Professor Wei Ruihua from the Eye Hospital of Tianjin Medical University, and Professor Li Yan from Peking University People’s Hospital.Address. Experts not only highlighted the national emphasis on myopia prevention and control, as well as the pioneering role of orthokeratology lenses in this field, but also extended their congratulations on the market launch of Tiantong orthokeratology lenses!
Tian TongTTOSGeneral Manager Wang DongDelivered a speech at the product launch event. Mr. Wang recounted the efforts made by Tiantong since introducing its technology to China in 2003, expressing the hope that Tiantong, like a morning star, would illuminate the path forward for every user. He pledged to lead Tiantong in continuous improvement, staying true to its original mission and forging ahead with determination.
With the official market launch of the TianTong TTOS product,The unveiling ceremony for the Shanghai “Chasing Light Youth” Special Fund for Myopia Prevention and Control in Children was also held.Ms. Wang Luning and Professor Zhou Xingtao were invited to unveil the plaque. The fund aims to fulfill social responsibilities through tripartite collaboration among public welfare organizations, medical institutions, and enterprises, contributing to ensuring that every child has a bright and beautiful world.
“Keep your eyes on the stars, and your feet on the ground.” The original aspiration behind the development of TianTong stemmed from clinical needs, while its continuous improvement and iterative upgrades have been grounded in real-world practice. For this launch event, TianTong has invitedProfessor Mao Xinjie of the Eye Hospital of Wenzhou Medical UniversityIt discusses the major trend toward personalized design of orthokeratology lenses,Professor Zhou Jiaqi of the Eye and ENT Hospital, Fudan UniversityDiscusses the Application of Defocus in Myopia Prevention and ControlProfessor Wang Kai, Optometry Center of Peking University People's HospitalDiscusses the importance of controlling the treatment optical zone,Professor Yang Xiao of the Zhongshan Ophthalmic Center, Sun Yat-sen UniversityThe Role of Precision BC Adjustment in Myopia ControlDirector Zhang Shuxian, Optometry Center, Tianjin Eye HospitalThis article describes the standardized procedures and efficient fitting techniques for orthokeratology lenses.
As a brand-new Chinese-made orthokeratology lens brand, TianTong’s growth from research and development to market launch has been inseparable from everyone’s support and care. The launch event also invited Professor Mao Xinjie from the Eye Hospital of Wenzhou Medical University; Professor Zhou Jiaqi from the Eye and ENT Hospital of Fudan University; Director Du Bei from the Eye Hospital of Tianjin Medical University; Director Li Shumao from Tianjin Eye Hospital; and Director Zhang Xiaofeng from Dushu Lake Hospital Affiliated to Soochow University to jointly review the milestones of TianTong in clinical studies.
Mr. Zhang Chunhua, the Company’s Product Training Manager, provided a detailed introduction to the four advantages of the Tiantong Orthokeratology Lens:Precision Adjustment Design: Ultimate optimization of the optical zone and all parameters; Precision Positioning Design: Dual AC parabolic center alignment; Precision Matching Design: Comprehensive matching of diameter and toricity; Precision Coverage Design: Simplified fitting with full clinical coverage.Through iterative product development of orthokeratology lenses, TianTong TTOS has expanded the eligible patient population, meeting the needs of more individuals. By integrating a simpler fitting methodology, it achieves superior visual quality and myopia control outcomes.
The launch event also invited TianTong’s first batch of partners and held a grand plaque-awarding ceremony, signaling that TianTong will work hand in hand with its partners to dedicate itself to providing higher-quality products and services to clinical experts and myopia patients.
The market launch is merely the beginning for TianTong. With vast horizons ahead, our journey promises to be brilliant! TianTong will remain true to its original mission, forge ahead with determination, and continuously strive for excellence, contributing its share to myopia prevention and control. Following the participation of leading ophthalmologists in China in TianTong’s Qiming Initiative, TianTong will continue to make significant contributions to myopia prevention and control, making unremitting efforts to improve the eye health of Chinese adolescents!